The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2021

Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2021

Publishing Date : Oct, 2021

License Type :
 

Report Code : 1417741

No of Pages : 111

Synopsis
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.

The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 4984.2 million in 2020 and is expected to reach US$ 6369.4 million by the end of 2027, growing at a CAGR of 3.1% during 2021-2027.
This report focuses on Congestive Heart Failure (CHF) Treatment Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Congestive Heart Failure (CHF) Treatment Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Congestive Heart Failure (CHF) Treatment Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Cardiac Resynchronization Therapy (CRT)
  • Implantable Cardioverter Defibrillators (ICDs)

Segment by Application

  • Left Ventricular Assist Device (LVAD)
  • Right Ventricular Assist Device (RVAD)
  • Biventricular Assist Device (BIVAD)

Consumption by Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Abiomed
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • HeartWare International
  • Jarvik Heart
  • LivaNova PLC
  • Medtronic
  • ReliantHeart
  • Abbott

Scope of the Congestive Heart Failure (CHF) Treatment Devices Market Report

Report Metric

Details

Report Name

Congestive Heart Failure (CHF) Treatment Devices Market

Market size in 2021

US$ 4984.2 Million

The revenue forecast in 2027

US$ 6369.4 Million

Growth Rate

CAGR of 3.1% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Congestive Heart Failure (CHF) Treatment Devices Market Overview
1.1 Product Overview and Scope of Congestive Heart Failure (CHF) Treatment Devices
1.2 Congestive Heart Failure (CHF) Treatment Devices Segment by Type
1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Cardiac Resynchronization Therapy (CRT)
1.2.3 Implantable Cardioverter Defibrillators (ICDs)
1.3 Congestive Heart Failure (CHF) Treatment Devices Segment by Application
1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Comparison by Application: (2021-2027)
1.3.2 Left Ventricular Assist Device (LVAD)
1.3.3 Right Ventricular Assist Device (RVAD)
1.3.4 Biventricular Assist Device (BIVAD)
1.4 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Estimates and Forecasts
1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2016-2027
1.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales 2016-2027
1.4.3 Congestive Heart Failure (CHF) Treatment Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Congestive Heart Failure (CHF) Treatment Devices Market Competition by Manufacturers
2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Sites, Area Served, Product Type
2.5 Congestive Heart Failure (CHF) Treatment Devices Market Competitive Situation and Trends
2.5.1 Congestive Heart Failure (CHF) Treatment Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players Market Share by Revenue
2.5.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario by Region
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.3.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country
3.3.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.4.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country
3.4.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region
3.5.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.6.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country
3.6.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country
3.7.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Analysis by Type
4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2021)
4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2016-2021)
4.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2016-2021)

5 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Analysis by Application
5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2021)
5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2016-2021)
5.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Abiomed
6.1.1 Abiomed Corporation Information
6.1.2 Abiomed Description and Business Overview
6.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.1.5 Abiomed Recent Developments/Updates
6.2 Berlin Heart GmbH
6.2.1 Berlin Heart GmbH Corporation Information
6.2.2 Berlin Heart GmbH Description and Business Overview
6.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.2.5 Berlin Heart GmbH Recent Developments/Updates
6.3 Biotronik SE & Co. KG
6.3.1 Biotronik SE & Co. KG Corporation Information
6.3.2 Biotronik SE & Co. KG Description and Business Overview
6.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.3.5 Biotronik SE & Co. KG Recent Developments/Updates
6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Corporation Information
6.4.2 Boston Scientific Corporation Description and Business Overview
6.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.4.5 Boston Scientific Corporation Recent Developments/Updates
6.5 HeartWare International
6.5.1 HeartWare International Corporation Information
6.5.2 HeartWare International Description and Business Overview
6.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.5.5 HeartWare International Recent Developments/Updates
6.6 Jarvik Heart
6.6.1 Jarvik Heart Corporation Information
6.6.2 Jarvik Heart Description and Business Overview
6.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.6.5 Jarvik Heart Recent Developments/Updates
6.7 LivaNova PLC
6.6.1 LivaNova PLC Corporation Information
6.6.2 LivaNova PLC Description and Business Overview
6.6.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.7.5 LivaNova PLC Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Corporation Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 ReliantHeart
6.9.1 ReliantHeart Corporation Information
6.9.2 ReliantHeart Description and Business Overview
6.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.9.5 ReliantHeart Recent Developments/Updates
6.10 Abbott
6.10.1 Abbott Corporation Information
6.10.2 Abbott Description and Business Overview
6.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.10.5 Abbott Recent Developments/Updates

7 Congestive Heart Failure (CHF) Treatment Devices Manufacturing Cost Analysis
7.1 Congestive Heart Failure (CHF) Treatment Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices
7.4 Congestive Heart Failure (CHF) Treatment Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Congestive Heart Failure (CHF) Treatment Devices Distributors List
8.3 Congestive Heart Failure (CHF) Treatment Devices Customers

9 Congestive Heart Failure (CHF) Treatment Devices Market Dynamics
9.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends
9.2 Congestive Heart Failure (CHF) Treatment Devices Growth Drivers
9.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges
9.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints

10 Global Market Forecast
10.1 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Congestive Heart Failure (CHF) Treatment Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Congestive Heart Failure (CHF) Treatment Devices by Type (2022-2027)
10.2 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Congestive Heart Failure (CHF) Treatment Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Congestive Heart Failure (CHF) Treatment Devices by Application (2022-2027)
10.3 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Congestive Heart Failure (CHF) Treatment Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Congestive Heart Failure (CHF) Treatment Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Covered in This Study
Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Congestive Heart Failure (CHF) Treatment Devices Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2021)
Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021)
Table 20. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2021)
Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2016-2021)
Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Type (2016-2021)
Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2021)
Table 45. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2016-2021)
Table 47. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Application (2016-2021)
Table 48. Abiomed Corporation Information
Table 49. Abiomed Description and Business Overview
Table 50. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product
Table 52. Abiomed Recent Developments/Updates
Table 53. Berlin Heart GmbH Corporation Information
Table 54. Berlin Heart GmbH Description and Business Overview
Table 55. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product
Table 57. Berlin Heart GmbH Recent Developments/Updates
Table 58. Biotronik SE & Co. KG Corporation Information
Table 59. Biotronik SE & Co. KG Description and Business Overview
Table 60. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product
Table 62. Biotronik SE & Co. KG Recent Developments/Updates
Table 63. Boston Scientific Corporation Corporation Information
Table 64. Boston Scientific Corporation Description and Business Overview
Table 65. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product
Table 67. Boston Scientific Corporation Recent Developments/Updates
Table 68. HeartWare International Corporation Information
Table 69. HeartWare International Description and Business Overview
Table 70. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product
Table 72. HeartWare International Recent Developments/Updates
Table 73. Jarvik Heart Corporation Information
Table 74. Jarvik Heart Description and Business Overview
Table 75. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product
Table 77. Jarvik Heart Recent Developments/Updates
Table 78. LivaNova PLC Corporation Information
Table 79. LivaNova PLC Description and Business Overview
Table 80. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product
Table 82. LivaNova PLC Recent Developments/Updates
Table 83. Medtronic Corporation Information
Table 84. Medtronic Description and Business Overview
Table 85. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product
Table 87. Medtronic Recent Developments/Updates
Table 88. ReliantHeart Corporation Information
Table 89. ReliantHeart Description and Business Overview
Table 90. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product
Table 92. ReliantHeart Recent Developments/Updates
Table 93. Abbott Corporation Information
Table 94. Abbott Description and Business Overview
Table 95. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Abbott Congestive Heart Failure (CHF) Treatment Devices Product
Table 97. Abbott Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Congestive Heart Failure (CHF) Treatment Devices Distributors List
Table 101. Congestive Heart Failure (CHF) Treatment Devices Customers List
Table 102. Congestive Heart Failure (CHF) Treatment Devices Market Trends
Table 103. Congestive Heart Failure (CHF) Treatment Devices Growth Drivers
Table 104. Congestive Heart Failure (CHF) Treatment Devices Market Challenges
Table 105. Congestive Heart Failure (CHF) Treatment Devices Market Restraints
Table 106. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 107. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Type (2022-2027)
Table 108. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 109. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Type (2022-2027)
Table 110. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 111. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Application (2022-2027)
Table 112. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 113. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Application (2022-2027)
Table 114. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 115. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Region (2022-2027)
Table 116. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 117. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Region (2022-2027)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Congestive Heart Failure (CHF) Treatment Devices
Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Type in 2020 & 2027
Figure 3. Cardiac Resynchronization Therapy (CRT) Product Picture
Figure 4. Implantable Cardioverter Defibrillators (ICDs) Product Picture
Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Application in 2020 & 2027
Figure 6. Left Ventricular Assist Device (LVAD)
Figure 7. Right Ventricular Assist Device (RVAD)
Figure 8. Biventricular Assist Device (BIVAD)
Figure 9. Global Congestive Heart Failure (CHF) Treatment Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Congestive Heart Failure (CHF) Treatment Devices Market Size 2016-2027 (US$ Million)
Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales 2016-2027 (K Units)
Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers in 2020
Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players: Market Share by Revenue in 2020
Figure 16. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2021)
Figure 18. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region in 2020
Figure 19. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2016-2021)
Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in 2020
Figure 21. U.S. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Type (2016-2021)
Figure 46. Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Application (2016-2021)
Figure 47. Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Application in 2020
Figure 48. Revenue Share of Congestive Heart Failure (CHF) Treatment Devices by Application (2016-2021)
Figure 49. Revenue Share of Congestive Heart Failure (CHF) Treatment Devices by Application in 2020
Figure 50. Manufacturing Cost Structure of Congestive Heart Failure (CHF) Treatment Devices
Figure 51. Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices
Figure 52. Congestive Heart Failure (CHF) Treatment Devices Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’